Taiwo Olabisi: Exploring the Promise of Factor XIa Inhibitors in Stroke Prevention
Taiwo Olabisi, Registered Nurse at Lasuth, shared a post on LinkedIn:
“Closed my laptop today feeling incredibly fulfilled. I just completed an advanced pharmacotherapy certification: ‘Less Bleeding, More Prevention: A Nurse-Focused Review of the Paradigm-Shifting Promise of Factor XIa Inhibitors in Secondary Stroke Prevention.’
While working in a busy surgical department, you quickly realize that patient care doesn’t stop when the surgery ends.
Post-op recovery is a critical window, and thromboembolic events (like strokes or deep vein clots) are risks we have to watch like a hawk every single shift.
Taking this course gave me a much deeper look into the latest low-bleed anticoagulation protocols, which means I can bring sharper eyes and better clinical judgment straight to the ward floor tomorrow.
Investing in my education is non-negotiable for me, especially as I keep looking toward global standards and expanding my horizons in healthcare.
One milestone at a time!”
Stay updated with Hemostasis Today.
-
Jun 17, 2026, 15:09A Comprehensive PROS1 Variants Database – JTH
-
Jun 17, 2026, 15:03Mavis Agnes Kisakye։ From Care Recipients to Self-Managers
-
Jun 17, 2026, 14:54Bruna Velosa Ferreira: PV and ET – Beyond Blood Count Control
-
Jun 17, 2026, 11:45Advancing Patient-Centred Innovation in Thalassaemia Care at EHA2026 – TIF
-
Jun 17, 2026, 11:37Alessandro Lucchesi: Mechanistic Biology as the Engine of Next-Generation Therapies
-
Jun 17, 2026, 11:23Gabriela Hobbs: Emerging Myelofibrosis Therapies at EHA 2026
-
Jun 17, 2026, 09:54Shadi Tabibian: Improving Outcomes Through Accurate VWD Subclassification
-
Jun 17, 2026, 09:47Nihal Mesmoudi: Inspired by Scientific Excellence at ICMES 2026
-
Jun 17, 2026, 09:26Nicolas Gendron: Join the Conversation on Antithrombotic Stewardship at ISTH 2026